Radiculopathy
is commonly known as pinched nerve. It is a condition where one or more nerves
are affected and stop performing its functions. This condition leads to pain,
weakness, numbness and difficulty in controlling certain muscles. The pain
generally occurs at the root of the nerve in radiculopathy. It also affects
that part of the body that the nerve serves. The causes of radiculopathy maybe
secondary to degenerative disc disease, osteoarthritis, facet joint
degeneration, or a combination of such factors. Some rare causes include
diabetes mellitus, neoplastic disease, radiation and so on.
Clinical
trials are conducted in medical research labs to find better ways to prevent
and treat diseases or diagnose them. They give solutions on the medical
approaches suitable for certain illness to a certain group of people
specifically. These trials help a great deal in making healthcare decisions.
Since they answer scientific questions, these trials are required to be carried
on under strict and scientific standards that protect the interests of the
patients. They are also the final and the most important stage of clinical
research and development. Clinical trials for drugs take place in four phases-
first, they test an experimental drug on a few people and study the effects;
second, they test the drug on more people than in Phase 1 which may extend up
to years; third, they include many other participants to test for safety and
efficacy and study the side effects deeper than in Phase 2; fourth, getting
approval of the usage of drug from the relevant authority.
Ken
Research’s Radiculopathy
Global Clinical Trials Review, H1, 2018 gives an overview of the global
clinical trials landscape and top-level data related to clinical trials by
Regio, Country (G7 and E7), Trial Status, trial Phase, Sponsor type and End
point status. The report reviews top companies involved and enlists all trials
(Trial title, Phase, and Status) pertaining to the company and all the
unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for
their non-accomplishments. It provides enrolment trends for the past five years
and the latest news relating to these trials for the past three months. The
companies involved in the clinical trials of Radiculopathy are Biogen Inc,
Semnur Pharmaceuticals Inc, Pfizer Inc, Pacira Pharmaceuticals Inc, CMAX,
Celgene Corp, BioAssets Development Corp, Aurous HealthCare Research and
Development India Pvt Ltd, Astellas Pharma Inc and Allodynic Therapeutics LLC.
The report will enhance the decision- making capabilities and helps to create
an effective counter strategy to gain competitive advantage.
For more information, click on the
link below:
Contact Us:
Ken
Research
Ankur
Gupta, Head Marketing & Communications
+91
9015378249